Orega Biotech Competitors and Similar CompaniesClear all
VCANBIO's competitors and similar companies include Spur Therapeutics.
 VCANBIO VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. |  Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | |
Founding Date | Founding Date 1993 | Founding Date 2015 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Tianjin, CN HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees 2,0149% decrease | Employees 122 |
Financial | ||
Revenue (est.) | Revenue (est.) ¥1.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥438.8m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥993.4m (FY, 2025) | Gross profit $8.9m (FY, 2022) |
Net income | Net income ¥103.5m (FY, 2025) | Net income ($89m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Spur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company